Sulforaphane downregulates mitochondrial TIGAR via inhibiting mitochondrial transmembrane assembly and LONP1/CASP3
Dongxue Wu1, Sitian Zhang2, Yaheng Wu3
1Neonatal Intensive Care Unit, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, China.
Abstract:
TP53-induced glycolysis and apoptosis regulator (TIGAR) was implicated to be a brand-new target for sulforaphane (SFN) in human non-small cell lung cancer (NSCLC), while the mechanism was elusive. We found that highly expressed TIGAR was positively correlated to pathological grading and contributed to poor survival in NSCLC patients. Western blot showed that SFN downregulated α-tubulin, TIGAR, Timm23 and Timm17A in cytosolic and/or mitochondrial lysate. Besides, SFN downregulated α-tubulin contributing to TIGAR reduction, and also decreased interactions of α-tubulin to Timm23, Timm17A and TIGAR in mitochondria; thus, SFN disrupted the microtubule-mediated mitochondrial transmembrane complexes blocking the entry of cytosolic TIGAR into mitochondria. Further, SFN downregulated mitoprotease LONP1 and decreased the binding of LONP1 to TIGAR; knockdown of LONP1 activated mitochondrial caspase-3 causing the cleavage of mitochondrial TIGAR; SFN-mediated the reduction of TIGAR decreased NADPH leading to ROS elevation and apoptosis in NSCLC. These studies will provide key targets for anti-NSCLC therapy.
Insights
Sulforaphane (SFN) targets TP53-induced glycolysis and apoptosis regulator (TIGAR) in non-small cell lung cancer (NSCLC). SFN disrupts TIGAR
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- TP53-induced glycolysis and apoptosis regulator (TIGAR) is upregulated in non-small cell lung cancer (NSCLC).
- High TIGAR expression correlates with poor prognosis and higher pathological grading in NSCLC patients.
- The precise mechanism by which sulforaphane (SFN) affects TIGAR in NSCLC remains unclear.
Purpose of the Study:
- To elucidate the mechanism of SFN's action on TIGAR in NSCLC.
- To investigate SFN's impact on TIGAR localization and function within NSCLC cells.
- To explore the potential of targeting TIGAR for anti-NSCLC therapy.
Main Methods:
- Western blot analysis of cytosolic and mitochondrial fractions.
- Immunoprecipitation to assess protein interactions.
- Analysis of reactive oxygen species (ROS) and apoptosis markers.
Main Results:
- SFN downregulates TIGAR, α-tubulin, Timm23, and Timm17A.
- SFN disrupts microtubule-mediated mitochondrial import of TIGAR by reducing α-tubulin interactions.
- SFN downregulates LONP1, leading to TIGAR cleavage, decreased NADPH, elevated ROS, and apoptosis.
Conclusions:
- SFN inhibits NSCLC progression by targeting TIGAR.
- Disruption of TIGAR's mitochondrial import and subsequent cleavage are key mechanisms.
- Targeting TIGAR and its related pathways presents a promising therapeutic strategy for NSCLC.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway
Cellular Injury V: Apoptosis and Autophagy


